Dedicated to advancing neurointerventional therapies for stroke

ABOUT NEURAVI   |   Fully focused on improving acute stroke treatment, Neuravi develops and globally markets innovative medical devices for neurointerventional therapy that are based upon extensive research into the clot and occlusions that cause stroke. Through its investment in the Neuravi Thromboembolic Initiative (NTI), Neuravi supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics, in order to improve patient outcomes in stroke.

Neuravi Thromboembolic Initiative

Interdisciplinary collaboration to further understanding of thromboembolic mechanics

Learn more →

EmboTrap Platform

The EmboTrap Revascularization Platform is a new minimally invasive therapeutic intervention for treating acute stroke

Learn more →

Clinical Studies

Neuravi is committed to developing clinical data to advance the treatment of stroke

Learn more →

Latest News

Codman Neuro Announces Acquisition of Neuravi Limited to Accelerate Innovation in Acute Ischemic Stroke Therapy

Learn more →